HE4 Promotes Events Associated with Metastatic Ovarian Cancer Via Regulation of the Extracellular Matrix

Hilary Gaudet,Jennifer Ribeiro,Mehreen Khan,Christoph Schorl,Nicole James,Matthew Oliver,Rakesh Singh,Paul DiSilvestro,Richard Moore,Naohiro Yano
DOI: https://doi.org/10.1096/fasebj.2018.32.1_supplement.804.1
2018-04-01
The FASEB Journal
Abstract:Human epididymis protein 4 (HE4) has diagnostic and prognostic abilities for epithelial ovarian cancer. The Risk of Malignancy Algorithm (ROMA) uses HE4 serum levels in combination with other factors to detect and monitor ovarian cancer. Several studies have demonstrated a role for HE4 in invasion and migration. Here, we further investigated the role of HE4 in events associated with metastatic ovarian cancer. Treatment of OVCAR8 ovarian cancer cells with recombinant HE4 (rHE4) promoted invasion, haptotaxis toward a fibronectin substrate, and adhesion onto fibronectin. In addition, overexpression of HE4 or treatment with rHE4 promoted the upregulation of transcripts coding for extracellular matrix proteins, including LAMC2 and LAMB3. Deposition of laminin‐332, the heterotrimer comprising LAMC2 and LAMB3 proteins, was increased in OVCAR8 cells treated with rHE4 or conditioned media from HE4‐overexpressing cells. Enzymatic activity of matriptase, a serine protease that cleaves laminin‐332 and contributes to its pro‐migratory functional activity, was enhanced by rHE4 treatment. Focal adhesion kinase signaling was activated in OVCAR8 cells treated with conditioned media from HE4‐overexpressing cells and focal adhesions were increased in cells treated with rHE4 in the presence of fibronectin. These results indicate a role for HE4 in mediating events associated with metastatic ovarian cancer. This abstract is from the Experimental Biology 2018 Meeting. There is no full text article associated with this abstract published in The FASEB Journal .
What problem does this paper attempt to address?